We are determined to develop novel and effective immunotherapies to provide patients with relevant treatment options in their fight against cancer. We thereby aim to build strategic alliances and program collaborations to make sure we can deliver on our promise to provide universally accessible solutions.

We believe that together with our partners we have an opportunity that could change the way how cancer combination therapies can be a source of improved health.

For more information to explore partnering opportunities, please contact us at